Teva
Teva launches biosimilar fertility treatment in the UK
January 8, 2016Manufacturing and Production, Sales and Marketing Ovaleap, Teva, biosimilar
Teva has launched its biosimilar version of Merck’s fertility treatment Gonal-f in the UK, potentially bringing a more affordable version …
Takeda and Teva set out generics joint venture plan
January 4, 2016Sales and Marketing Takeda, Teva, generics, joint venture
Takeda and Teva have detailed plans for a new joint venture to create a new company to market off-patent generic …
Teva strips $1 billion worth of assets to clear Allergan deal
December 4, 2015Medical Communications, Sales and Marketing Allergan, Teva, acquisitions, divestments, mergers
Teva Pharmaceuticals is thought to be in the process of stripping nearly $1 billion worth of assets to address antitrust …
Teva and Heptares enter $400m agreement for small-molecule migraine treatment
November 25, 2015Research and Development Heptares, Teva, collaboration, migraine
Teva Pharmaceuticals and Heptares Therapeutics have signed a licensing and drug-discovery agreement for Teva to gain exclusive global rights to …
Pfizer in ‘friendly’ merger talks with Allergan
October 29, 2015Sales and Marketing Actavis, Allergan, Pfizer, Teva
Pfizer is in talks with Allergan over what could be the largest takeover deal in an already record-breaking year, it …
Teva joins Watson Health in R&D link-up
October 14, 2015Research and Development Big Data, R&D, Teva, Watson Health, ibm
Teva has partnered with the IBM Watson Health Cloud to create a global technology platform to aid its R&D efforts …
Teva acquires Mexico’s Rimsa for $2.3 billion
October 5, 2015Research and Development, Sales and Marketing Mexico, Rimsa, Teva, mergers and acquisitions
Strategic Move Enhances Teva’s Presence in Mexico, the Second Largest Market in Latin America and a Major Emerging Market Brings a Portfolio of …
Teva buys majority stake in genomic analysis firm
August 4, 2015Manufacturing and Production, Research and Development, Sales and Marketing CNS, Immuneering, Teva, central nervous system, genetic analysis
Teva has agreed to by a 51% equity share of genomic-analysis company Immuneering to advance treatments for diseases of the …
Teva to switch generics focus to Allergan
July 27, 2015Sales and Marketing Allergan, Teva, generics, mergers and acquisitions, pharma mergers and acquisitions
Teva is in negotiations to buy Allergan’s generics division for upwards of $40 billion, according to reports. The generics firm …
Teva ‘to increase Mylan bid to $43bn’
July 7, 2015Sales and Marketing M&A, MA, Mylan, Teva, generics
Israeli drugmaker Teva is considering whether to up its bid for US rival firm Mylan, with reports that it could …
FDA accepts Teva asthma drug for review
June 15, 2015Sales and Marketing AstraZeneca, GlaxoSmithKline’s mepolizumab, Teva, benralizumab, bla, cinquil, reslizumab
Teva’s investigational biologic for the treatment of inadequately controlled asthma in patients with elevated blood eosinophils, Cinquil, has been accepted …
Perrigo buys OTC products from GSK
June 3, 2015Sales and Marketing GSK, GlaxoSmithKline, Mylan, Perrigo, Teva, brett wells
In an all-cash move with no financial details disclosed Perrigo is buying a portfolio of leading over-the-counter products from GlaxoSmithKline. …
Mylan tells Teva to ‘stop playing games’ and make firm bid
June 2, 2015Manufacturing and Production, Sales and Marketing M&A, MA, Mylan, Teva, generics
Mylan has written another strongly-worded letter to Teva, this time accusing the Israeli firm of ‘playing games’ and violating US …
Teva settles generic ‘pay-to-delay’ case for $1.2 billion
May 29, 2015Sales and Marketing Cephalon, FTC, Teva, modafinil, provigil
Teva Pharmaceuticals has agreed to a $1.2 billion settlement for paying generic drug makers to delay challenging the patent for …
Teva lifted by positive migraine drug results
May 15, 2015Sales and Marketing TEV-48125, Teva, headaches, migraine
Patients who take either dose of Teva’s investigational treatment for chronic migraine improve more than those taking a placebo according …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
